Gastrointestinal Cancer News

A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the manufacturer.

Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.

Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.

A consortium recommended classifying people with a high risk for pancreatic cancer into subtypes based on family history and germline variants, according to findings published in Journal of the National Comprehensive Cancer Network.

Researchers are launching an all-telehealth precision oncology trial that will include patients with pancreatic cancer whose tumors have the same genetic mutation.

Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.

The addition of durvalumab to chemotherapy doubled 3-year survival among patients with advanced biliary tract cancers, according to data released by the agent’s manufacturer.

Detection of colorectal cancer was “rare” at surveillance colonoscopy among patients aged 70 to 85 years, and although detection of advanced neoplasia was higher, overall yields did not increase significantly with age, researchers reported.

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.